| 07:30 - 08:00 |
Tea / Coffee Break, Exhibition & Poster Viewing - Assembly I & II |
| |
Plenary I
Venue: Senate I & II |
| |
Chairperson: Prof Charles Swanepoel |
| 08:00 - 08:45 |
Registries and RCTs
Fergus Caskey (UK) |
| 08:45 - 09:30 |
Rare Genetic Diseases of the kidney - challenges and opportunities
Vivek Jha (India) |
| 09:30 - 09:45 |
Tea / Coffee Break, Exhibition & Poster Viewing - Assembly I & II
Sponsored by AMGEN |
| |
Adult & Paediatric Nephrology Combined
Venue: Senate I and II |
|
RCCSA
Venue: NCC |
|
Workshops
Venue: Julia |
| |
Chairperson: Dr Geoff Bihl |
|
Chairpersons: Mr Mark Padavattan and Dr Esme De Beer |
|
Chairpersons: Dr Brett Cullis and Nicola Wearne |
| 09:45 - 10:00 |
Abstract Presentation
Genetic associations with onset and progression of focal segmental glomerulosclerosis (FSGS) in black South African children
Melanie Ann Govender (SA) |
09:45 - 10:30 |
Unphysiology and reverse epidemiology of dialysis
Ivor Katz (Australia) |
09:45 - 11:30 |
Adcock Ingram Critical Care Home choice Claria Workshop: APD Prescription - Remote patient monitoring
Nicola Wearne |
| 10:00 - 10:15 |
Abstract Presentation
Use of 'Home-Made Pd' adapted intravenous fluid solution for acute peritoneal dialysis in Africa
Mignon McCulloch (SA) |
10:30 - 10:45 |
Abstract Presentation
Analysis of chronic haemodialysis population demographics and outcomes in a private practice in Johannesburg
Zakariyah Gangat (SA) |
| 10:15 - 10:30 |
Abstract Presentation
The complications of peritoneal dialysis in children with end-stage renal disease in Johannesburg, South Africa: A 5 year experience
Tholang Khumalo (SA) |
10:45 - 11:00 |
Abstract Presentation
Comparative Analysis of Urea Reduction Ratios (Urr) of chronic renal failure patients on nocturnal and diurnal haemodialysis treatment
T Jugdeo (SA) |
11:30 - 13:00 |
Adcock Ingram Critical Care Prismaflex Workshop: Indications, timings and dosing of CRRT
Brett Cullis |
| 10:30 - 10:45 |
Abstract Presentation
The state of kidney transplantation in South Africa
Rafique Moosa (SA) |
| 10:45 - 11:00 |
Abstract Presentation
Did improving procedural fairness in the allocation of dialysis access by application of 'Accountability for Reasonableness' in the Western Cape have the desired outcome?
Rafique Moosa (SA) |
| 11:00 - 11:45 |
SA Renal Registry Annual Report 2016 and update on the African Renal Registry
Razeen Davids (SA) |
11:00 - 11:45 |
Risk stratification and management in kidney transplant
Viji Rajakumari (India) |
| 11:45 - 12:30 |
Adolescent risks
Mignon McCulloch |
11:45 - 12:30 |
Renal dialysis - a funders perspective
Jenni Noble-Luckhoff (SA) |
| 12:30 - 13:00 |
Arresting progression of nephropathy in Sickle Cell Disease
Fatiu Arogundade (Nigeria) |
12:30 - 13:00 |
Panel Discussion: NHI and the future of medical aids
Moremi Nkosi (SA)
Jenni Noble-Luckhoff (SA) |
| 13:00 - 14:00 |
Lunch Break, Exhibition & Poster Viewing - Assembly I & II |
Lunch Symposium: "Fabry Disease"
Shoyab Wadee (SA)
Senate I & II
Sponsored by Shire Pharmaceuticals |
|
Adult & Paediatric Nephrology Combined
Venue: Senate I and II |
|
RCCSA
Venue: NCC |
|
Workshops
Venue: Julia |
|
Chairperson: Prof Saraladevi Naicker |
|
Chairpersons: Dr Chevon Clark and Reena Moodley |
|
Chairperson: TBA |
| 14:00 - 14:45 |
Collecting patient outcomes, audit & research: lessons from the UK Renal Registry
Fergus Caskey (UK) |
14:00 - 14:45 |
Ethical considerations in end-stage renal disease
Munyadziwa Kwinda - HPCSA |
14:00 - 16:30 |
High-volume HDF: Time to shift the renal replacement paradigm and improve patient outcomes
Fresenius Medical Care Symposium:
"High-volume HDF: Time to shift the renal replacement paradigm and improve patient outcomes"
High Volume HDF - outcome and evidence
Bernard Canaud
How to optimize convective dose
Fatih Kircelli
|
| 14:45 - 15:30 |
Public health approach to kidney disease (Prevention, priority, ethical challenges)
Valerie Luyckx (Switzerland) |
14:45 - 15:30 |
Management of vascular access
Pradeep Mistry (SA) |
| 15:30 - 16:00 |
Tea / Coffee Break, Exhibition & Poster Viewing - Assembly I & II
Sponsored by AMGEN |
|
Adult & Paediatric Nephrology Combined
Venue: Senate I and II |
|
RCCSA
Venue: NCC |
|
Workshops
Venue: Julia |
|
Chairperson: Prof Razeen Davids |
|
Chairpersons: Dr Karlien van Jaarsveld and Dr Stephanie Viljoen |
|
Chairperson: TBA |
| 16:00 - 16:15 |
Abstract Presentation
Anaemia mean corpuscular volume and mortality among a black CKD population in South Africa
Aishatu Muhammad Nalado (SA) |
16:00 - 16:30 |
Improving vascular access outcomes - A nursing model
Yanella Martinez-Smith (Australia) |
16:30 - 17:45 |
High Volume HDF vs. HDx - efficacy and safety
Bernard Canaud
Fresenius Medical Care Symposium:
"Peritoneal Dialysis Advances"
APD therapy
Sleep Safe harmony benefits
Fatih Kircelli
Benefits of Ultralow GDP
Fatih Kircelli
Benefits of pure bicarbonate PD fluid br>
Fatih Kircelli
|
| 16:15 - 16:30 |
Abstract Presentation
An audit of treatment of AKI in SADC and Nigeria: are we ready for zero deaths by 2025 in sub-Saharan Africa?
Erika Jones (SA) |
| 16:30 - 16:45 |
Abstract Presentation
Using the urinary biomarker MCP-1 to assess disease activity in lupus nephritis - A pilot study
Jody Alan Rusch (SA) |
16:30 - 16:45 |
Abstract Presentation
Implementing strategic change in a selected private healthcare company in South Africa: The importance of leadership and change readiness
Edmund Jacobs (SA) |
| 16:45 - 17:00 |
Abstract Presentation
The influence of dialysis modality on post transplant outcomes
Reece Boosi (SA) |
16:45 - 17:00 |
Abstract Presentation
Assessing the effectiveness of management tools in healthcare: A case study of the Quadruple Aim Model at a private dialysis company in South Africa
Chevon Clark (SA) |
| 17:00 - 17:15 |
Abstract Presentation
Plasma Fibroblast Growth Factor 23 and All- Cause Mortality in South African Patients on Maintenance Haemodialysis
Bala Waziri (SA) |
17:00 - 17:45 |
Ultrasound in vascular access
Pradeep Mistry (SA) |
| 17:15 - 17:30 |
Abstract Presentation
Sensitivity and specificity of anti-phospholipase A2 receptor (APLA2R) a and thrombospondin type-1 domain-containing 7a (THSD7A) in identifying idiopathic membranous nephropathy in a South African cohort
Bingileki. F. Lwezaula (SA) |
|
|
|
|
| 17:00 - 17:45 |
SARS Executive Committee Meeting |
| 17:45 - 18:00 |
Preparation |
| 18:00 - 18:30 |
SARS AGM (Members Only) |
| 18:00 - 18:30 |
Dialysis and the future of private practice - Panel discussion
(SARS Members only) |
